Genetic characterization of Pseudomonas aeruginosa bacteriophage KPP10

Jumpei Uchiyama1, Mohammad Rashel, Iyo Takemura

  • 1Department of Microbiology and Infection, Faculty of Medicine, Kochi University, Kohasu, Oko-cho, Nankoku, Kochi, 783-8505, Japan.

Archives of Virology
|January 6, 2012
PubMed

Insights

Bacteriophage KPP10, a lytic phage targeting P. aeruginosa, is suitable for phage therapy. Its genome analysis revealed no pathogenicity or lysogenization factors, confirming its therapeutic potential.

Area of Science:

  • Microbiology
  • Genomics
  • Bacteriophage Therapy

Background:

  • Bacteriophage (phage) KPP10 has been explored for experimental phage therapies against Pseudomonas aeruginosa infections.
  • Assessing the genomic characteristics of phage KPP10 is crucial to determine its suitability for therapeutic applications.

Purpose of the Study:

  • To analyze the genome of bacteriophage KPP10.
  • To evaluate its potential as a therapeutic agent against P. aeruginosa.

Main Methods:

  • Genomic DNA sequencing of phage KPP10.
  • Open reading frame (ORF) prediction and analysis.
  • Comparative genomic analysis with related phages.

Main Results:

  • Phage KPP10 possesses an 88,322 bp genome with 158 predicted ORFs and three tRNA genes.
  • No ORFs encoded for pathogenicity or lysogenization factors.
  • Phage KPP10, along with phage PAK_P3, represents a novel group of lytic phages infecting P. aeruginosa.

Conclusions:

  • Phage KPP10 is a lytic bacteriophage.
  • The absence of pathogenicity and lysogenization factors in its genome supports its use in phage therapy.
  • Phage KPP10 is a promising candidate for therapeutic interventions against P. aeruginosa infections.